anthracyclines

Preferred Label : anthracyclines;

MeSH definition : Organic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.;

MeSH synonym : Anthracycline;

Wikipedia link : https://en.wikipedia.org/wiki/Anthracycline;

Is substance : O;

Details

Origin ID

D018943;

UMLS CUI

C0282564;

ATC code(s)
- anthracyclines and related substances [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Anthracycline (substance) [SNOMED CT concept]
- Anthracycline Antineoplastic Antibiotic [NCIt concept]
- anthracyclines and related substances [ATC Code]
Record concept(s)
- anthracyclines [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,4-bis(2-(2,2-dimethyloxazolidin-3-yl)ethylamino)-1,4-didehydroxypyrromycinone [MeSH Supplementary Concept]
- 1,6-hexamethyleneaminoisocyanate [MeSH Supplementary Concept]
- 1-hydroxyauramycin A [MeSH Supplementary Concept]
- 1-hydroxyauramycin B [MeSH Supplementary Concept]
- 1-hydroxyoxaunomycin [MeSH Supplementary Concept]
- 1-hydroxysulfurmycin A [MeSH Supplementary Concept]
- 1-hydroxysulfurmycin B [MeSH Supplementary Concept]
- 10-O-rhodosaminyl beta-rhodomycinone [MeSH Supplementary Concept]
- 10-daunosaminyl-epsilon-rhodomycinone [MeSH Supplementary Concept]
- 10-dihydrosteffimycin [MeSH Supplementary Concept]
- 10-dihydrosteffimycin B [MeSH Supplementary Concept]
- 10-rhamnosyl-epsilon-rhodomycinone [MeSH Supplementary Concept]
- 11-O-xylosylpradimicin FH [MeSH Supplementary Concept]
- 11-O-xylosylpradimicin H [MeSH Supplementary Concept]
- 11-deoxyoxaunomycin [MeSH Supplementary Concept]
- 11-deoxyrhodomycinone 2,3,6-trideoxy-3-dimethylaminohexopyranoside [MeSH Supplementary Concept]
- 11-deoxyrhodomycinone 2,3,6-trideoxy-4-oxohexopyranosyl-(1-4)-2,6-dideoxyhexopyranosyl-(1-4)-2,3,6-trideoxy-3-dimethylaminohexopyranoside [MeSH Supplementary Concept]
- 11-deoxyrhodomycinone 4-O-(heptahydro-2,9-dimethyl-1,4-dioxane(2,3-b-6,5-c')dipyran-3(4H)-one-7-yl)-2,3,6-trideoxy-3-dimethylaminohexopyranoside [MeSH Supplementary Concept]
- 14-O-methylbenanomicin A [MeSH Supplementary Concept]
- 18-O-demethylcervinomycin A2 [MeSH Supplementary Concept]
- 2'-demethylbenanomicin A [MeSH Supplementary Concept]
- 2,8-demethoxysteffimycin [MeSH Supplementary Concept]
- 2-demethylsteffimycin D [MeSH Supplementary Concept]
- 2-hydroxyaklavinone [MeSH Supplementary Concept]
- 3'-O-demethyl mutactimycin [MeSH Supplementary Concept]
- 3'-hydroxybenanomicin A [MeSH Supplementary Concept]
- 3-demethoxy-3-ethoxytetracenomycin C [MeSH Supplementary Concept]
- 4-O,3'-O-didemethyl mutactimycin [MeSH Supplementary Concept]
- 4-O-(2',6'-dideoxyhexopyranosyl)-1,2,3,4-tetrahydro-2,4,5,12-tetrahydroxy-2-hydroxymethyl-6,11-naphthacenedione [MeSH Supplementary Concept]
- 4-O-methyl-13-hydroxyoxaunomycin [MeSH Supplementary Concept]
- 4-O-methyl-6-deoxyoxaunomycin [MeSH Supplementary Concept]
- 4-O-methylbetaclamycin T [MeSH Supplementary Concept]
- 4-O-methylepelmycin D [MeSH Supplementary Concept]
- 4-O-methyloxaunomycin [MeSH Supplementary Concept]
- 4-O-methylyellamycin A [MeSH Supplementary Concept]
- 4-demethoxyanthracycline [MeSH Supplementary Concept]
- 5-iminoaranciamycin [MeSH Supplementary Concept]
- 6,8,11-trihydroxy-8-methyl-10-((4-morpholino-2,4,6-trideoxy-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione [MeSH Supplementary Concept]
- 6-deoxyoxaunomycin [MeSH Supplementary Concept]
- 7-O-(3-amino-2,3,6-trideoxy-alpha-hexopyranosyl)-epsilon-isorhodomycinone [MeSH Supplementary Concept]
- 7-deoxypyrromycinone [MeSH Supplementary Concept]
- 8-demethoxysteffimycin [MeSH Supplementary Concept]
- 9-O-methylbenanomicin A [MeSH Supplementary Concept]
- 9-deoxybenanomicin A [MeSH Supplementary Concept]
- A 51493A [MeSH Supplementary Concept]
- BE 19412A [MeSH Supplementary Concept]
- BE 19412B [MeSH Supplementary Concept]
- BM 2419-1 [MeSH Supplementary Concept]
- BM 2419-2 [MeSH Supplementary Concept]
- CG 10 [MeSH Supplementary Concept]
- CG 11 [MeSH Supplementary Concept]
- CG1-C antibiotic [MeSH Supplementary Concept]
- CG21-C antibiotic [MeSH Supplementary Concept]
- DRAQ7 fluorescent probe [MeSH Supplementary Concept]
- FRALLE 93 protocol [MeSH Supplementary Concept]
- IT 62-B [MeSH Supplementary Concept]
- MEN 11079 [MeSH Supplementary Concept]
- N,N-dimethylpradimicin C [MeSH Supplementary Concept]
- N,N-dimethylpradimicin E [MeSH Supplementary Concept]
- N,N-dimethylpradimicin FA-2 [MeSH Supplementary Concept]
- N05WA963C [MeSH Supplementary Concept]
- OS 4742 [MeSH Supplementary Concept]
- PI 083 [MeSH Supplementary Concept]
- SN-07 [MeSH Supplementary Concept]
- SO 75R1 [MeSH Supplementary Concept]
- SS 288A [MeSH Supplementary Concept]
- SS 288B [MeSH Supplementary Concept]
- TAN 1120 [MeSH Supplementary Concept]
- WP 744 [MeSH Supplementary Concept]
- WP760 [MeSH Supplementary Concept]
- akrobomycin [MeSH Supplementary Concept]
- alcindoromycin [MeSH Supplementary Concept]
- alldimycin A [MeSH Supplementary Concept]
- alldimycin B [MeSH Supplementary Concept]
- alldimycin C [MeSH Supplementary Concept]
- alpha-citromycinone [MeSH Supplementary Concept]
- amrubicin [MeSH Supplementary Concept]
- amrubicinol [MeSH Supplementary Concept]
- anhydromaggiemycin [MeSH Supplementary Concept]
- anthrapyrazole [MeSH Supplementary Concept]
- antibiotic 80334 C [MeSH Supplementary Concept]
- antibiotic 80334 F [MeSH Supplementary Concept]
- antibiotic A447 C [MeSH Supplementary Concept]
- antibiotic A447 D [MeSH Supplementary Concept]
- antibiotic M-13-1 [MeSH Supplementary Concept]
- antibiotic M-3 [MeSH Supplementary Concept]
- antibiotic M-4 [MeSH Supplementary Concept]
- aranciamycin [MeSH Supplementary Concept]
- aranciamycin I [MeSH Supplementary Concept]
- aranciamycin J [MeSH Supplementary Concept]
- arugomycin [MeSH Supplementary Concept]
- auramycin A [MeSH Supplementary Concept]
- auramycin B [MeSH Supplementary Concept]
- auramycin C [MeSH Supplementary Concept]
- auramycin D [MeSH Supplementary Concept]
- auramycin E [MeSH Supplementary Concept]
- auramycin F [MeSH Supplementary Concept]
- auramycin G [MeSH Supplementary Concept]
- auramycinone [MeSH Supplementary Concept]
- avidinorubicin [MeSH Supplementary Concept]
- balmoralmycin [MeSH Supplementary Concept]
- barminomycin I [MeSH Supplementary Concept]
- barminomycin II [MeSH Supplementary Concept]
- benanomicin A [MeSH Supplementary Concept]
- benanomicin B [MeSH Supplementary Concept]
- benanomicinone [MeSH Supplementary Concept]
- beromycin, anthracycline [MeSH Supplementary Concept]
- betaclamycin A [MeSH Supplementary Concept]
- betaclamycin B [MeSH Supplementary Concept]
- bis(anhydro)aklavinone [MeSH Supplementary Concept]
- bohemic acid complex [MeSH Supplementary Concept]
- cervimycin C [MeSH Supplementary Concept]
- cervinomycin A1 [MeSH Supplementary Concept]
- cervinomycin A1 triacetate [MeSH Supplementary Concept]
- cervinomycin A2 [MeSH Supplementary Concept]
- cervinomycin A2 monoacetate [MeSH Supplementary Concept]
- cinerubin R [MeSH Supplementary Concept]
- cinerubin X [MeSH Supplementary Concept]
- cinerubine A [MeSH Supplementary Concept]
- cinerubine B [MeSH Supplementary Concept]
- collinemycin [MeSH Supplementary Concept]
- cororubicin [MeSH Supplementary Concept]
- cosmomycin A' [MeSH Supplementary Concept]
- cosmomycin B [MeSH Supplementary Concept]
- cosmomycin B' [MeSH Supplementary Concept]
- cosmomycin C [MeSH Supplementary Concept]
- cosmomycin D [MeSH Supplementary Concept]
- cytorhodin X [MeSH Supplementary Concept]
- decilorubicin [MeSH Supplementary Concept]
- dexylosylbenanomicin A [MeSH Supplementary Concept]
- dexylosylbenanomicin B [MeSH Supplementary Concept]
- ditrisarubicin A [MeSH Supplementary Concept]
- ditrisarubicin B [MeSH Supplementary Concept]
- ditrisarubicin C [MeSH Supplementary Concept]
- dutomycin [MeSH Supplementary Concept]
- epelmycin A [MeSH Supplementary Concept]
- epelmycin B [MeSH Supplementary Concept]
- epelmycin C [MeSH Supplementary Concept]
- epelmycin D [MeSH Supplementary Concept]
- epelmycin E [MeSH Supplementary Concept]
- epsilon-isorhodomycinone [MeSH Supplementary Concept]
- epsilon-pyrromycinone [MeSH Supplementary Concept]
- ericamycin [MeSH Supplementary Concept]
- estrone-3-hemisuccinate-doxorubicin [MeSH Supplementary Concept]
- eta-isorhodomycinone [MeSH Supplementary Concept]
- galtamycin [MeSH Supplementary Concept]
- galtamycin B [MeSH Supplementary Concept]
- himalomycin A [MeSH Supplementary Concept]
- himalomycin B [MeSH Supplementary Concept]
- iremycin [MeSH Supplementary Concept]
- keyicin [MeSH Supplementary Concept]
- kyanomycin [MeSH Supplementary Concept]
- maggiemycin [MeSH Supplementary Concept]
- marcellomycin [MeSH Supplementary Concept]
- micromonomycin [MeSH Supplementary Concept]
- monoanhydroaklavinone [MeSH Supplementary Concept]
- morpholinoanthracycline MX [MeSH Supplementary Concept]
- morpholinoanthracycline MY5 [MeSH Supplementary Concept]
- musettamycin [MeSH Supplementary Concept]
- mutactimycin E [MeSH Supplementary Concept]
- mutactimycin PR [MeSH Supplementary Concept]
- nocardicyclin A [MeSH Supplementary Concept]
- nocardicyclin B [MeSH Supplementary Concept]
- nothramicin [MeSH Supplementary Concept]
- obelmycin A [MeSH Supplementary Concept]
- obelmycin D [MeSH Supplementary Concept]
- obelmycin E [MeSH Supplementary Concept]
- obelmycin F [MeSH Supplementary Concept]
- obelmycin G [MeSH Supplementary Concept]
- obelmycin H [MeSH Supplementary Concept]
- oxaunomycin [MeSH Supplementary Concept]
- pillaromycin A [MeSH Supplementary Concept]
- pillaromycinone [MeSH Supplementary Concept]
- pradimicin A [MeSH Supplementary Concept]
- pradimicin B [MeSH Supplementary Concept]
- pradimicin D [MeSH Supplementary Concept]
- pradimicin E [MeSH Supplementary Concept]
- pradimicin FA 1 [MeSH Supplementary Concept]
- pradimicin FA 2 [MeSH Supplementary Concept]
- pradimicin FB [MeSH Supplementary Concept]
- pradimicin FH [MeSH Supplementary Concept]
- pradimicin FL [MeSH Supplementary Concept]
- pradimicin FS [MeSH Supplementary Concept]
- pradimicin H [MeSH Supplementary Concept]
- pradimicin L [MeSH Supplementary Concept]
- pradimicin N [MeSH Supplementary Concept]
- pradimicin Q [MeSH Supplementary Concept]
- pradimicin S [MeSH Supplementary Concept]
- pradimicin T1 [MeSH Supplementary Concept]
- pradimicin T2 [MeSH Supplementary Concept]
- pradimicin-IRD [MeSH Supplementary Concept]
- pradimicinone [MeSH Supplementary Concept]
- pyrromycin [MeSH Supplementary Concept]
- requinomycin [MeSH Supplementary Concept]
- resomycin A [MeSH Supplementary Concept]
- resomycin B [MeSH Supplementary Concept]
- resomycin C [MeSH Supplementary Concept]
- respinomycin A1 [MeSH Supplementary Concept]
- respinomycin A2 [MeSH Supplementary Concept]
- respinomycin B [MeSH Supplementary Concept]
- respinomycin C [MeSH Supplementary Concept]
- respinomycin D [MeSH Supplementary Concept]
- retamycin [MeSH Supplementary Concept]
- rhodilunancin A [MeSH Supplementary Concept]
- rhodomycin [MeSH Supplementary Concept]
- rhodomycinone [MeSH Supplementary Concept]
- rhodosaminylanthracyclinone antibiotics [MeSH Supplementary Concept]
- ro 313294 [MeSH Supplementary Concept]
- rodorubicin [MeSH Supplementary Concept]
- roseorubicins [MeSH Supplementary Concept]
- rubeomycin B [MeSH Supplementary Concept]
- rudolfomycin [MeSH Supplementary Concept]
- ruticulomycin [MeSH Supplementary Concept]
- saquayamycin Z [MeSH Supplementary Concept]
- schaunardimycin [MeSH Supplementary Concept]
- spartanamicin A [MeSH Supplementary Concept]
- spartanamicin B [MeSH Supplementary Concept]
- steffimycin [MeSH Supplementary Concept]
- steffimycin B [MeSH Supplementary Concept]
- steffimycin C [MeSH Supplementary Concept]
- sulfurmycin A [MeSH Supplementary Concept]
- sulfurmycin B [MeSH Supplementary Concept]
- sulfurmycin C [MeSH Supplementary Concept]
- sulfurmycin D [MeSH Supplementary Concept]
- sulfurmycinone [MeSH Supplementary Concept]
- taurimycin [MeSH Supplementary Concept]
- tetracenomycin A2 [MeSH Supplementary Concept]
- tetracenoquinocin [MeSH Supplementary Concept]
- verotetrone [MeSH Supplementary Concept]
- viriplanin A [MeSH Supplementary Concept]
- yellamycin A [MeSH Supplementary Concept]
- yellamycin B [MeSH Supplementary Concept]
- yellamycin C [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients